Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Antioxid Redox Signal ; 23(18): 1424-38, 2015 Dec 20.
Article in English | MEDLINE | ID: mdl-26054424

ABSTRACT

AIMS: Invasive fungal infections have significantly increased over the past decades in immunocompromised individuals and high-risk patients. Amphotericin B (AmB) exerts a powerful and broad activity against a vast array of fungi and has a remarkably low rate of microbial resistance. However, most isolates of Aspergillus terreus developed an intrinsic resistance against AmB, and during this study, we characterized the mode of action of this polyene antifungal drug in more detail in resistant (ATR) and rare susceptible (ATS) clinical isolates of A. terreus. RESULTS: We illustrate that AmB treatment changes cellular redox status and promotes the generation of high levels of reactive oxygen species (ROS) in ATS. In contrast, ATR isolates were able to cope better with AmB-induced oxidative stress. INNOVATION: Most importantly, we demonstrate in this study that coapplication of anti- and pro-oxidants significantly affects AmB efficacy in an antithetic manner--antioxidants and ROS-scavenging agents increase AmB tolerance in susceptible strains, while pro-oxidants render formerly resistant isolates considerably susceptible to the antifungal drug also in vivo in a Galleria animal model. CONCLUSION: Thereby, our study provides novel therapeutic options to treat formerly resistant fungal strains by a combination of AmB and pro-oxidant compounds.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillus/drug effects , Drug Resistance, Fungal , Aspergillus/genetics , Aspergillus/metabolism , DNA, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/genetics , Oxygen Consumption/drug effects , Reactive Oxygen Species/metabolism
2.
Antimicrob Agents Chemother ; 59(7): 3778-88, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25870060

ABSTRACT

The polyene antifungal amphotericin B (AmB) is widely used to treat life-threatening fungal infections. Even though AmB resistance is exceptionally rare in fungi, most Aspergillus terreus isolates exhibit an intrinsic resistance against the drug in vivo and in vitro. Heat shock proteins perform a fundamental protective role against a multitude of stress responses, thereby maintaining protein homeostasis in the organism. In this study, we elucidated the role of heat shock protein 70 (Hsp70) family members and compared resistant and susceptible A. terreus clinical isolates. The upregulation of cytoplasmic Hsp70 members at the transcriptional as well as translational levels was significantly higher with AmB treatment than without AmB treatment, particularly in resistant A. terreus isolates, thereby indicating a role of Hsp70 proteins in the AmB response. We found that Hsp70 inhibitors considerably increased the susceptibility of resistant A. terreus isolates to AmB but exerted little impact on susceptible isolates. Also, in in vivo experiments, using the Galleria mellonella infection model, cotreatment of resistant A. terreus strains with AmB and the Hsp70 inhibitor pifithrin-µ resulted in significantly improved survival compared with that achieved with AmB alone. Our results point to an important mechanism of regulation of AmB resistance by Hsp70 family members in A. terreus and suggest novel drug targets for the treatment of infections caused by resistant fungal isolates.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillus/drug effects , HSP70 Heat-Shock Proteins/antagonists & inhibitors , Sulfonamides/pharmacology , Animals , Aspergillosis/drug therapy , Drug Resistance, Fungal/drug effects , Drug Therapy, Combination , Microbial Sensitivity Tests , Moths/microbiology
3.
J Infect Dis ; 212(7): 1140-9, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-25810442

ABSTRACT

BACKGROUND: Platelets were recently identified as a part of innate immunity. They are activated by contact with Aspergillus fumigatus; putative consequences include antifungal defense but also thrombosis, excessive inflammation, and thrombocytopenia. We aimed to identify those fungal surface structures that mediate interaction with platelets. METHODS: Human platelets were incubated with Aspergillus conidia and hyphae, isolated wall components, or fungal surface mutants. Interaction was visualized microscopically; activation was quantified by flow cytometry of specific markers. RESULTS: The capacity of A. fumigatus conidia to activate platelets is at least partly due to melanin, because this effect can be mimicked with "melanin ghosts"; a mutant lacking melanin showed reduced platelet stimulating potency. In contrast, conidial hydrophobin masks relevant structures, because an A. fumigatus mutant lacking the hydrophobin protein induced stronger platelet activation than wild-type conidia. A. fumigatus hyphae also contain surface structures that interact with platelets. Wall proteins, galactomannan, chitin, and ß-glucan are not the relevant hyphal components; instead, the recently identified fungal polysaccharide galactosaminogalactan potently triggered platelet activation. CONCLUSIONS: Conidial melanin and hydrophobin as well as hyphal galactosaminogalactan represent important pathogenicity factors that modulate platelet activity and thus might influence immune responses, inflammation, and thrombosis in infected patients.


Subject(s)
Antigens, Surface/immunology , Aspergillosis/microbiology , Aspergillus fumigatus/physiology , Blood Platelets/microbiology , Fungal Proteins/immunology , Melanins/immunology , Aspergillus fumigatus/chemistry , Blood Platelets/ultrastructure , Chitin/immunology , Flow Cytometry , Humans , Hyphae/chemistry , Hyphae/physiology , Immunity, Innate/immunology , Platelet Activation , Polysaccharides/immunology , Spores, Fungal/chemistry , Spores, Fungal/physiology , Virulence Factors/immunology , beta-Glucans/immunology
4.
Med Microbiol Immunol ; 202(5): 379-89, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23722593

ABSTRACT

Aspergillus terreus-induced invasive infections exhibit high lethality, partly due to the intrinsic resistance for amphotericin B (AmB). We compared the virulence and pathogenesis of an AmB-resistant isolate of A. terreus (ATR) with that of a rare variant showing enhanced sensitivity for AMB (ATS). The modifications that result in enhanced AmB sensitivity of isolates are not associated with reduced virulence in vivo; instead, the ATS-infected mice died even faster than the ATR-infected animals. Since A. terreus enters the blood stream in most patients and frequently induces thrombosis, we studied a putative correlation between virulence of the two A. terreus isolates and their effect on thrombocytes. Those mice infected with the more virulent ATS isolate had lower thrombocyte numbers and more phosphatidylserine exposure on platelets than ATR-infected mice. In vitro experiments confirmed that ATS and ATR differ in their effect on thrombocytes. Conidia, aleurioconidia and hyphae of ATS were more potent than ATR to trigger thrombocyte stimulation, and thrombocytes adhered better to ATS than to ATR fungal structures. Furthermore, ATS secreted more soluble factors that triggered platelet stimulation than ATR. Thus, it might be suggested that the capacity of a fungal isolate to modulate thrombocyte parameters contributes to its virulence in vivo.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillosis/microbiology , Aspergillosis/pathology , Aspergillus/pathogenicity , Blood Platelets/microbiology , Animals , Aspergillus/drug effects , Blood Platelets/physiology , Cell Adhesion , Disease Models, Animal , Drug Resistance, Fungal , Female , Healthy Volunteers , Humans , Mice , Mice, Inbred BALB C , Survival Analysis , Thrombocytopenia , Virulence
5.
Med Mycol ; 51(8): 876-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23758105

ABSTRACT

We compared two PCR methods for molecular typing the medically important filamentous fungus Aspergillus terreus. In a set of 46 strains investigated we found 19 and 12 different fingerprinting types obtained by random amplified polymorphic DNA PCR (RAPD) and semi-automated repetitive element PCR (rep-PCR), respectively.


Subject(s)
Aspergillus/classification , Aspergillus/genetics , Molecular Typing/methods , Mycological Typing Techniques/methods , Aspergillosis/epidemiology , Aspergillosis/microbiology , Aspergillus/isolation & purification , DNA Fingerprinting/methods , DNA, Fungal/genetics , Humans , Interspersed Repetitive Sequences , Molecular Epidemiology/methods
6.
Antimicrob Agents Chemother ; 57(4): 1583-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23318794

ABSTRACT

Amphotericin B (AMB) is the predominant antifungal drug, but the mechanism of resistance is not well understood. We compared the in vivo virulence of an AMB-resistant Aspergillus terreus (ATR) isolate with that of an AMB-susceptible A. terreus isolate (ATS) using a murine model for disseminated aspergillosis. Furthermore, we analyzed the molecular basis of intrinsic AMB resistance in vitro by comparing the ergosterol content, cell-associated AMB levels, AMB-induced intracellular efflux, and prooxidant effects between ATR and ATS. Infection of immunosuppressed mice with ATS or ATR showed that the ATS strain was more lethal than the ATR strain. However, AMB treatment improved the outcome in ATS-infected mice while having no positive effect on the animals infected with ATR. The in vitro data demonstrated that ergosterol content is not the molecular basis for AMB resistance. ATR absorbed less AMB, discharged more intracellular compounds, and had better protection against oxidative damage than the susceptible strain. Our experiments showed that ergosterol content plays a minor role in intrinsic AMB resistance and is not directly associated with intracellular cell-associated AMB content. AMB might exert its antifungal activity by oxidative injury rather than by an increase in membrane permeation.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillus/pathogenicity , Drug Resistance, Fungal/physiology , Amphotericin B/pharmacology , Animals , Antifungal Agents/pharmacology , Aspergillus/drug effects , Aspergillus/metabolism , Drug Resistance, Fungal/genetics , Lipid Peroxidation/drug effects , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests
7.
Mycopathologia ; 174(5-6): 467-74, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22864604

ABSTRACT

In vitro susceptibility testing of clinically important fungi becomes more and more essential due to the rising number of fungal infections in patients with impaired immune system. Existing standardized microbroth dilution methods for in vitro testing of molds (CLSI, EUCAST) are not intended for routine testing. These methods are very time-consuming and dependent on sporulating of hyphomycetes. In this multicentre study, a new (independent of sporulation) inoculum preparation method (containing a mixture of vegetative cells, hyphae, and conidia) was evaluated. Minimal inhibitory concentrations (MIC) of amphotericin B, posaconazole, and voriconazole of 180 molds were determined with two different culture media (YST and RPMI 1640) according to the DIN (Deutsches Institut für Normung) microdilution assay. 24 and 48 h MIC of quality control strains, tested per each test run, prepared with the new inoculum method were in the range of DIN. YST and RPMI 1640 media showed similar MIC distributions for all molds tested. MIC readings at 48 versus 24 h yield 1 log(2) higher MIC values and more than 90 % of the MICs read at 24 and 48 h were within ± 2 log(2) dilution. MIC end point reading (log(2 MIC-RPMI 1640)-log(2 MIC-YST)) of both media demonstrated a tendency to slightly lower MICs with RPMI 1640 medium. This study reports the results of a new, time-saving, and easy-to-perform method for inoculum preparation for routine susceptibility testing that can be applied for all types of spore-/non-spore and hyphae-forming fungi.


Subject(s)
Antifungal Agents/pharmacology , Fungi/drug effects , Fungi/growth & development , Microbial Sensitivity Tests/methods , Culture Media/chemistry , Culture Media/metabolism , Fungi/metabolism , Hyphae/drug effects , Hyphae/growth & development
8.
Mycoses ; 55(3): 237-43, 2012 May.
Article in English | MEDLINE | ID: mdl-21797937

ABSTRACT

The aim of this study was to investigate the relationship between fungal exposure prior to hospitalisation and ensuing onset of invasive mould infections (IMI) in patients at risk. Patients admitted to the Department of Haematology, Oncology and Transplant Surgery of the Medical University Innsbruck received a questionnaire regarding fungal exposure prior to hospital stay. Questions inquired heavy fungal exposures up to 5 days before hospitalisation. A total of 234 patients were enrolled in this study. Multiple fungus exposures were associated with the onset of community-acquired IMI in patients with haematological malignancies. In univariate analysis, haematological malignancies (P = 0.013) and allergy to dust, pollen or moulds (P = 0.015) were significantly associated with fungal infections. In multivariate analysis, logistic regression showed that haematological patients (P = 0.015) and patients with allergy (P = 0.015) were significantly more frequently infected with fungi. Hospital-independent fungal sources highlight risk-factors for IMI in severe immunocompromised patients and the rate of community-acquired IMI does increase.


Subject(s)
Air Microbiology , Aspergillus/physiology , Candida/physiology , Community-Acquired Infections/epidemiology , Immunocompromised Host , Inhalation Exposure/adverse effects , Mycoses/epidemiology , Adult , Aspergillus/isolation & purification , Candida/genetics , Candida/isolation & purification , Cohort Studies , Community-Acquired Infections/immunology , Community-Acquired Infections/microbiology , Female , Hospitalization , Humans , Male , Middle Aged , Mycoses/immunology , Mycoses/microbiology , Risk Factors
9.
Salud(i)ciencia (Impresa) ; 18(6): 543-546, oct. 2011.
Article in Spanish | LILACS | ID: lil-646682

ABSTRACT

Las infecciones micóticas invasivas (IMI) constituyen una importante causa de morbimortalidad, en especial en los pacientes con factores de riesgo subyacentes (neutropenia, quimioterapia, trasplante, sida). Las especies de los géneros Candida y Aspergillus representan aun las causas relevantes de IMI, pero otros organismos están adquiriendo importancia creciente. Han surgido especies del género Aspergillus menos sensibles a los antifúngicos y se ha encontrado resistencia a los azólicos, especialmente en Aspergillus fumigatus. Asimismo, las infecciones debidas a especies de los géneros Trichosporon, Fusarium y Glomeromycota (antes llamado Zygomycetes) se han incrementado y se asocian con altas tasas de mortalidad. Algunas de estas infecciones emergentes se presentan como brotes durante el tratamiento con nuevos antifúngicos, como las equinocandinas o los azólicos. La incidencia, gravedad y pronóstico de las IMI dependen de manera acentuada del organismo causal, el estado del paciente, el nivel de inmunosupresión y la localización geográfica. El diagnóstico precoz y el reconocimiento de estos cambios epidemiológicos son críticos para la atención de los pacientes.


Subject(s)
Aspergillus , Candida/classification , Infection Control , Epidemiology , Mitosporic Fungi/classification , Mitosporic Fungi/metabolism , Mitosporic Fungi/virology
10.
Antimicrob Agents Chemother ; 52(4): 1553-5, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18268082

ABSTRACT

This study investigated the basis for intrinsic amphotericin B (AMB) resistance in Aspergillus terreus. The ergosterol content, cell wall composition, and lipid peroxidation level had no influence on AMB resistance. The level of catalase production in A. terreus was significantly higher than that in A. fumigatus (P < 0.05). This higher-level production may contribute to AMB resistance in A. terreus since oxidative damage has been implicated in AMB action.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillus/classification , Aspergillus/drug effects , Catalase/biosynthesis , Drug Resistance, Fungal , Aspergillosis , Aspergillus/enzymology , Humans , Microbial Sensitivity Tests
11.
Int J Antimicrob Agents ; 29(4): 424-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17276041

ABSTRACT

This study examined the direct interaction of serotonin (5-hydroxytryptamine (5-HT)) with Aspergillus species. Accumulation of 5-HT in aspergilli was investigated by immunofluorescence staining and laser confocal scanning microscopy. The influence of 5-HT on fungal ergosterol content, cell membrane integrity, fungal growth and hyphal elongation was determined. 5-HT was localised in the cytoplasm of Aspergillus spp., as 5-HT fluorescent signals appeared after 30min at 4 degrees C and in the presence of inhibitors of oxidative phosphorylation. 5-HT treatment of Aspergillus spp. significantly affected ergosterol synthesis, fungal cell membrane integrity and hyphal elongation (P<0.05). 5-HT treatment for 4h resulted in a lag of re-growth (post-antifungal effect). In conclusion, our findings suggest that 5-HT affects hyphal growth and diminishes fungal cell membrane integrity.


Subject(s)
Antifungal Agents/pharmacology , Aspergillus/drug effects , Aspergillus/physiology , Serotonin/pharmacology , Aspergillus/growth & development , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Ergosterol/metabolism , Fluorescent Antibody Technique, Indirect , Oxidation-Reduction , Phosphorylation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...